Stocks with the largest changes before the market opens: Versant, Biogen, Bullish, Cisco and others
Pre-Market Trading Highlights In pre-market trading, several companies are experiencing notable shifts. Biogen saw a share increase of 4% after announcing its Alzheimer’s drug advancement to a Phase 3 trial, despite not meeting the main goal of its Phase 2 trial. The company stated that there were positive effects on cognitive function. Versant Media Group’s […]
Biogen walks away from controversial Alzheimer’s drug Aduhelm
Pharmaceutical company Biogen announced Wednesday that it will relinquish ownership of its Alzheimer’s disease drug Aduhhelm, which sparked intense criticism of the company and the Food and Drug Administration (FDA) after it was approved in 2021. The company will also halt ongoing post-approval clinical trials ordered by the FDA to determine the drug’s effectiveness in […]